Wedbush Lowers Earnings Estimates for Compass Therapeutics
Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) – Analysts at Wedbush cut their FY2028 EPS estimates for Compass Therapeutics in a note issued to investors on Tuesday, April 1st. Wedbush analyst R. Driscoll now anticipates that the company will post earnings per share of $1.17 for the year, down from their previous forecast of $1.36. […]
Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) – Analysts at Wedbush cut their FY2028 EPS estimates for Compass Therapeutics in a note issued to investors on Tuesday, April 1st. Wedbush analyst R. Driscoll now anticipates that the company will post earnings per share of $1.17 for the year, down from their previous forecast of $1.36. […]
